Beyond its role in cell cycle progression, FOXM1 has been shown to contribute to other important oncogenic phenotypes in ovarian cancer, including platinum and taxane resistance, epithelial-to-mesenchymal transition (EMT), cell migration, and cell invasion [52–55]. This evidence concerns the gene FOXM1 and ovarian cancer.